President Donald Trump said his view of Iran's leaders changed because he got to know them during a press briefing on Wednesday [1].
The shift in rhetoric signals a hardening of the U.S. position toward Tehran, moving from a perception of strategic rationality to one of fundamental instability.
Speaking at the NATO summit in Ankara, Turkey, Trump said he reversed how he characterizes the Iranian government [2]. He previously described the leaders as "rational, nice, strong and smart," but now refers to them as "sick people" [3].
Trump said the change in his assessment came from direct interactions with Iranian officials, which he said gave him a better understanding of their character [4]. This pivot occurred during the two-day summit [5].
While the president focused on the personal nature of his misjudgment during the briefing, other reports indicate a more aggressive posture. Trump said Iran's leadership is a "cancer" that needs to be cut out [6].
Some reports suggest the president's view has shifted toward seeing Tehran as a direct personal threat. According to some sources, he has labeled Iran as his "number one target" and suggested that the leadership in Tehran wants him dead [7].
The remarks come as the U.S. continues to navigate complex security dynamics within the NATO alliance. The briefing in Ankara served as a platform for the president to clarify his current stance on regional adversaries [2].
“"I got to know them."”
This shift in language suggests a move away from a diplomacy-first approach based on the perceived rationality of the adversary. By reclassifying the Iranian leadership as 'sick' or a 'cancer,' the administration creates a rhetorical framework where negotiation may be viewed as futile, potentially justifying more aggressive unilateral actions or sanctions to isolate the regime.
